320 related articles for article (PubMed ID: 11786416)
21. Enhanced atherosclerosis in Lp(a) WHHL transgenic rabbits.
Fan J; Sun H; Unoki H; Shiomi M; Watanabe T
Ann N Y Acad Sci; 2001 Dec; 947():362-5. PubMed ID: 11795291
[TBL] [Abstract][Full Text] [Related]
22. Vascular cell adhesion molecule-1 up-regulation and phenotypic modulation of vascular smooth muscle cells predate mononuclear infiltration in transplant arteriopathy.
Sai S; Iwata A; Thomas R; Allen MD
J Thorac Cardiovasc Surg; 2001 Sep; 122(3):508-17. PubMed ID: 11547303
[TBL] [Abstract][Full Text] [Related]
23. Endothelial derived vasorelaxation is impaired in human APO A-I transgenic rabbits.
Lebuffe G; Boullier A; Tailleux A; Delfly B; Dupuis B; Fruchart JC; Duverger N; Emmanuel F; Denefle P; Vallet B; Duriez P
Biochem Biophys Res Commun; 1997 Dec; 241(1):205-11. PubMed ID: 9405258
[TBL] [Abstract][Full Text] [Related]
24. [Lipoprotein Lp(a) and CETP (cholesterol ester transfer protein): contribution of transgenic mice].
Chapman J; Guérin M
Bull Acad Natl Med; 1994 Mar; 178(3):427-34; discussion 434-6. PubMed ID: 8076182
[TBL] [Abstract][Full Text] [Related]
25. [Research progress in lipoprotein (a): aspects of biochemistry and molecular biology].
Huang YT
Sheng Li Ke Xue Jin Zhan; 1996 Jan; 27(1):25-30. PubMed ID: 8731979
[TBL] [Abstract][Full Text] [Related]
26. Lipoprotein(a) in atherosclerotic plaques recruits inflammatory cells through interaction with Mac-1 integrin.
Sotiriou SN; Orlova VV; Al-Fakhri N; Ihanus E; Economopoulou M; Isermann B; Bdeir K; Nawroth PP; Preissner KT; Gahmberg CG; Koschinsky ML; Chavakis T
FASEB J; 2006 Mar; 20(3):559-61. PubMed ID: 16403785
[TBL] [Abstract][Full Text] [Related]
27. The role of lipoprotein(a) in atherogenesis and thrombosis.
Hajjar KA; Nachman RL
Annu Rev Med; 1996; 47():423-42. PubMed ID: 8712793
[TBL] [Abstract][Full Text] [Related]
28. Dual effect of apolipoprotein(a) on plasmin(ogen)-induced apoptosis through modulation of cell detachment of adherent cells.
Ho-Tin-Noé B; Meilhac O; Rossignol P; Lijnen HR; Anglés-Cano E
Thromb Haemost; 2006 Jan; 95(1):142-50. PubMed ID: 16543973
[TBL] [Abstract][Full Text] [Related]
29. Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (apo) A-I with severe hypercholesterolaemia.
Boullier A; Hennuyer N; Tailleux A; Furman C; Duverger N; Caillaud JM; Castro G; Fievet C; Fruchart JC; Duriez P
Clin Sci (Lond); 2001 Mar; 100(3):343-55. PubMed ID: 11222122
[TBL] [Abstract][Full Text] [Related]
30. Apolipoprotein(a) deposition in atherosclerotic plaques of cerebral vessels. A potential role for endothelial cells in lesion formation.
Jamieson DG; Usher DC; Rader DJ; Lavi E
Am J Pathol; 1995 Dec; 147(6):1567-74. PubMed ID: 7495281
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-I-transgenic rabbits.
Duverger N; Kruth H; Emmanuel F; Caillaud JM; Viglietta C; Castro G; Tailleux A; Fievet C; Fruchart JC; Houdebine LM; Denefle P
Circulation; 1996 Aug; 94(4):713-7. PubMed ID: 8772693
[TBL] [Abstract][Full Text] [Related]
32. Lipoprotein(a), atherosclerosis, and apolipoprotein(a) gene polymorphism.
Pati U; Pati N
Mol Genet Metab; 2000; 71(1-2):87-92. PubMed ID: 11001801
[TBL] [Abstract][Full Text] [Related]
33. Monocyte/macrophage accumulation and smooth muscle cell phenotypes in early atherosclerotic lesions of human aorta.
Babaev VR; Bobryshev YV; Sukhova GK; Kasantseva IA
Atherosclerosis; 1993 May; 100(2):237-48. PubMed ID: 8357356
[TBL] [Abstract][Full Text] [Related]
34. Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis.
Caplice NM; Panetta C; Peterson TE; Kleppe LS; Mueske CS; Kostner GM; Broze GJ; Simari RD
Blood; 2001 Nov; 98(10):2980-7. PubMed ID: 11698280
[TBL] [Abstract][Full Text] [Related]
35. [Lipoprotein(a): characteristics of a special lipoprotein and its potential clinical significance].
Armstrong VW
Ther Umsch; 1990 Jun; 47(6):475-81. PubMed ID: 2142832
[TBL] [Abstract][Full Text] [Related]
36. Studies of lipoprotein (a) and high density lipoproteins in transgenic mice.
Rubin EM
Atherosclerosis; 1994 Oct; 110 Suppl():S77-81. PubMed ID: 7857389
[TBL] [Abstract][Full Text] [Related]
37. Transgenic rabbits expressing human apolipoprotein (a).
Fan J; Watanabe T
J Atheroscler Thromb; 2000; 7(1):8-13. PubMed ID: 11425047
[TBL] [Abstract][Full Text] [Related]
38. Lipoprotein (a) in the regulation of fibrinolysis.
Edelberg JM; Pizzo SV
J Atheroscler Thromb; 1995; 2 Suppl 1():S5-7. PubMed ID: 9225222
[TBL] [Abstract][Full Text] [Related]
39. Proliferation of smooth muscle cells in acute allograft vascular rejection.
Amano J; Ishiyama S; Nishikawa T; Tanaka H; Nagai R; Marumo F; Hiroe M
J Thorac Cardiovasc Surg; 1997 Jan; 113(1):19-25. PubMed ID: 9011689
[TBL] [Abstract][Full Text] [Related]
40. Conditioned medium from HepG2 cells transfected with human apolipoprotein(a) gene stimulates growth of human vascular smooth muscle cells: effects of overexpression of human apolipoprotein(a) gene.
Morishita R; Yamada S; Higaki J; Tomita N; Kida I; Aoki M; Moriguchi A; Hayashi S; Sakurabayashi I; Kaneda Y; Ogihara T
Hypertension; 1998 Aug; 32(2):215-22. PubMed ID: 9719045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
